Is prednisolone (corticosteroid) safe to use during pregnancy?

Is Prednisolone Safe in Pregnancy?

Prednisolone can be used during pregnancy when clinically necessary to control active maternal disease, but should be tapered to the lowest effective dose (ideally ≤5 mg/day) to minimize dose-dependent maternal and fetal risks. 1

Key Safety Principles

Prednisolone is NOT associated with major birth defects or increased rates of stillbirth, preterm delivery, or congenital malformations when used for disease control. 1 This is the most important reassurance from the highest quality evidence.

Why Prednisolone Over Other Corticosteroids

• Prednisolone is 90% inactivated by placental 11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2), meaning only 10% of the maternal dose reaches the fetus. 1, 2
• Betamethasone and dexamethasone are far less inactivated by the placenta and have greater fetal exposure, making prednisolone the preferred choice for maternal disease control. 1
• This placental protection remains intact even in complicated pregnancies like HELLP syndrome. 2

Dose-Dependent Risks to Consider

Low-Dose (≤5 mg/day)

• Daily doses ≤5 mg are associated with low risk for both mother and fetus. 1
• This is the target maintenance dose whenever possible. 1

Higher Doses (>5 mg/day)

When higher doses are required, monitor for:

• Gestational diabetes mellitus (dose-dependent risk) 1, 3
• Preeclampsia 4
• Preterm birth 1
• Serious maternal infections 1
• Pregnancy-associated osteoporosis (with prolonged use) 1
• Intrauterine growth restriction/low birthweight 1, 4

Adrenal Suppression Risk

• Women taking >5 mg/day for more than 3 weeks are at risk for adrenal suppression and require increased glucocorticoid dosing at delivery, during intercurrent infection, vomiting, or hyperemesis gravidarum. 1, 3

First Trimester Considerations

The Cleft Palate Controversy

• Older data suggested an association between first-trimester prednisolone use and cleft lip/palate, but more recent studies have NOT confirmed this association. 1, 5
• The 2009 EASL guidelines mention increased risk of cleft palate 1, but the 2023 EASL guidelines and 2025 EULAR guidelines clarify that more recent evidence does not support this concern. 1
• Current consensus: prednisolone is not associated with increased major birth defects. 1

When to Avoid in First Trimester

• Do not use prednisolone for benign, self-limited conditions in the first trimester when safer alternatives exist. 4
• The risk-benefit calculation must favor disease control over theoretical medication risks. 4

Clinical Scenarios Where Prednisolone Is Appropriate

Autoimmune Disease

• Prednisolone ± azathioprine should be continued during pregnancy in women with autoimmune hepatitis to prevent disease flares, which are more dangerous than the medication itself. 1
• Disease flares during pregnancy or postpartum pose greater risk to maternal and fetal outcomes than controlled medication use. 1

Transplant Recipients

• Immunosuppressive drugs including prednisolone should NOT be stopped in pregnant transplant recipients. 1

Severe Refractory Disease

• For organ- or life-threatening maternal disease, IV methylprednisolone pulses can be used safely throughout pregnancy. 1

Practical Management Algorithm

1. Before pregnancy: Optimize disease control and taper to lowest effective dose
2. During pregnancy:
   • Target maintenance dose ≤5 mg/day when possible 1
   • Screen for gestational diabetes (especially if >5 mg/day) 1, 3
   • Monitor blood pressure for preeclampsia 3
   • Assess for adrenal suppression if >5 mg/day for >3 weeks 1
3. At delivery: Consider stress-dose steroids if on >5 mg/day for >3 weeks 1
4. Postpartum: Monitor for disease flare (especially autoimmune conditions) 1

Neonatal Considerations

• Neonates born to mothers on prednisolone should be observed for signs of hypoadrenalism. 6
• Passive transfer of maternal IgG antibodies (in autoimmune conditions) may cause transient neonatal manifestations that resolve within 4 weeks. 1

Lactation

• Prednisolone is considered safe during breastfeeding, as very little enters breast milk. 1, 7, 8

Common Pitfalls to Avoid

• Do not withhold necessary prednisolone due to outdated concerns about cleft palate - the most recent high-quality evidence does not support this association. 1
• Do not use betamethasone or dexamethasone for maternal disease control - these cross the placenta more readily than prednisolone. 1
• Do not forget to plan for stress-dose steroids at delivery if the patient has been on >5 mg/day for >3 weeks. 1
• Do not use prednisolone for conditions that don't require it (e.g., to improve IVF implantation rates, where it is not indicated). 5